PSYCHOSOCIAL ASPECTS IN COLORECTAL CANCER PATIENTS STAGE DUKES B2 &C

被引：0
|
作者：
Heras, P. [1 ]
Hatzopoulos, A. [1 ]
Hera, M. [1 ]
Kritikos, K. [1 ]
机构：
[1] Hellenic Med Soc Study Pshychosomat Problems, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：I53 / I53
页数：1
相关论文
共 50 条
  • [31] Prediction of recurrence in Dukes B colorectal cancer patients using molecular profiling
    Skarlas, Lambros
    Antonacopoulou, Anna
    Likothanassis, Spiridon
    Kalofonou, Melpomeni
    Kalofonos, Haralabos
    ANNALS OF ONCOLOGY, 2006, 17 : 252 - 252
  • [32] INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER
    MOERTEL, CG
    FLEMING, TR
    MACDONALD, JS
    HALLER, DG
    LAURIE, JA
    TANGEN, CM
    UNGERLEIDER, JS
    EMERSON, WA
    TORMEY, DC
    GLICK, JH
    VEEDER, MH
    MAILLIARD, JA
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2936 - 2943
  • [33] A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY IN DUKES B2 AND C1,2 COLON CANCER FOLLOWING CURATIVE RESECTION
    RICHARDS, F
    SPURR, C
    WHITE, D
    MUSS, H
    COOPER, M
    JACKSON, D
    MCCULLOCH, J
    SILLMON, D
    MACFARLAND, R
    GEILS, G
    ANDERSON, D
    SMITH, R
    CONNELLY, R
    CASE, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 200 - 200
  • [34] A TRIAL OF NONSPECIFIC IMMUNOTHERAPY USING SYSTEMIC C-PARVUM IN TREATED PATIENTS WITH DUKES B AND C COLORECTAL-CANCER
    SOUTER, RG
    GILL, PG
    MORRIS, PJ
    BRITISH JOURNAL OF CANCER, 1982, 45 (04) : 506 - 512
  • [35] Predicting recurrence and metastasis of stage III/Dukes' C colorectal cancer with lymph node metastasis
    Mukai, M
    Sato, S
    Kimura, T
    Ninomiya, H
    Komatsu, N
    Tajima, T
    Nakasaki, H
    Makuuchi, H
    ONCOLOGY REPORTS, 2004, 12 (06) : 1301 - 1304
  • [36] B1 versus B2 Dukes Stage Rectal Cancer: Prospective Evaluation of 87 Patients in a Single Institution and Quest for Re-evaluation of the Current Protocol
    Costea, Radu
    Zarnescu, Narcis Octavian
    Vasiliu, Eugenia Claudia
    Minca, Dana
    Sajin, Maria
    Neagu, Stefan
    HEPATO-GASTROENTEROLOGY, 2012, 59 (113) : 98 - 100
  • [37] ASCOLT: ASPIRIN FOR DUKES B AND HIGH-RISK DUKES C COLORECTAL CANCERS
    Segelov, Eva
    Zielinski, Robert
    Asghari, Ray
    Simes, John
    Yip, Sonia
    Coote, Alison
    Friend, Cheryl
    Aiken, Christine
    Whay, John Chia
    Jeffery, Mark
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 167 - 168
  • [38] The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease
    Evans, M. D.
    Barton, K.
    Rees, A.
    Stamatakis, J. D.
    Karandikar, S. S.
    COLORECTAL DISEASE, 2008, 10 (02) : 157 - 164
  • [39] Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
    Halling, KC
    French, AJ
    McDonnell, SK
    Burgart, LJ
    Schaid, DJ
    Peterson, BJ
    Moon-Tasson, L
    Mahoney, MR
    Sargent, DJ
    O'Connell, MJ
    Witzig, TE
    Farr, GH
    Goldberg, RM
    Thibodeau, SN
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (15): : 1295 - 1303
  • [40] Prognastic values of micrornas in patients with Dukes' B and C colon cancer
    Karaayvaz, M.
    Pal, T.
    Song, B.
    Zhang, C.
    Geogakopoulos, P.
    Mehmood, S.
    Burke, S.
    Shroyer, K.
    Ju, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345